MiNK Therapeutics, Inc.·4

Jan 6, 5:21 PM ET

Corvese Brian 4

4 · MiNK Therapeutics, Inc. · Filed Jan 6, 2026

Insider Transaction Report

Form 4
Period: 2026-01-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2026-01-02+5,3955,395 total
    Exercise: $11.12Exp: 2036-01-02Common Stock (5,395 underlying)
Footnotes (1)
  • [F1]Option vests on February 2, 2026, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4